GIUFFRE RANDALL MICHAEL received a stock award from DIAMEDICA THERAPEUTICS INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/3/2025ACC: 0001235802-25-000004
Director
Since Dec 2018
+10.86K
Net shares
Net buyer
$58.0K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
10.86K acquired
Non-Derivative Transactions1
Voting Common Shares, no par value per share
Direct
Shares
+10.86K
Price / share
$5.34
Trade value
$58K
% of position
3.0%
1/2/2025
364.55K→375.41K
Total
Net shares
+10.86K
Net value
$58K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Voting Common Shares, no par value per share Direct | 1/2/2025 | A · Award | +10.86K | $5.34 | $58K | 3.0% | 364.55K | 375.41K |
| Total | +10.86K | $58K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Voting Common Shares, no par value per share
IndirectShares owned21.07K
Voting Common Shares, no par value per share
IndirectShares owned25.57K
Total
46.64K indirect46.64K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Voting Common Shares, no par value per share | 21.07K | Indirect |
| Voting Common Shares, no par value per share | 25.57K | Indirect |
| Total | 46.64K | 46.64K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported